Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action

Neurocritical Care

(2014) Fawaz Al-Mufti et al.   CRITICAL CARE CLINICS

Brivaracetam for the treatment of epilepsy in adults

(2014) Marco Mula   Expert Review of Neurotherapeutics

Status Epilepticus: An Update

(2013) Panayiotis N. Varelas et al.   Current Neurology and Neuroscience Reports

Psychiatric comorbidities and premature death in epilepsy

(2013) Andres M. Kanner   Nature Reviews Neurology

Treatment of Status Epilepticus: An International Survey of Experts

(2012) James J. Riviello et al.   Neurocritical Care

Guidelines for the Evaluation and Management of Status Epilepticus

(2012) Gretchen M. Brophy et al.   Neurocritical Care

Intramuscular versus Intravenous Therapy for Prehospital Status Epilepticus

(2012) Robert Silbergleit et al.   NEW ENGLAND JOURNAL OF MEDICINE

Levetiracetam as alternative stage two antiepileptic drug in status epilepticus: A systematic review

(2012) Johan Zelano et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Cisterna magna cannulated repeated CSF sampling rat model – effects of a gamma-secretase inhibitor on Aβ levels

(2011) Jennifer S. Shapiro et al.   JOURNAL OF NEUROSCIENCE METHODS

Treatment Options in the Management of Status Epilepticus

(2010) Andrea O. Rossetti   Current Treatment Options in Neurology

Prediction of the in vitro permeability determined in Caco-2 cells by using artificial neural networks

(2010) Paulo Paixão et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The Permeation of Neutral Molecules, Ions, and Ionic Species Through Membranes: Brain Permeation as an Example

(2010) Michael H. Abraham   JOURNAL OF PHARMACEUTICAL SCIENCES

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men

(2008) Paul Rolan et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A

(2008) A Matagne et al.   BRITISH JOURNAL OF PHARMACOLOGY

Seizures and Status Epilepticus in the Intensive Care Unit

(2008) Wendy Ziai et al.   SEMINARS IN NEUROLOGY